Fabio De Gregorio

Vice President, Head of Drug Safety Europe, UK QPPV - Shionogi Europe

Dr De Gregorio serves as Vice President and Head of Drug Safety at Shionogi Europe, where he leads the European pharmacovigilance team. He has more than 25-year experience in different pharmaceutical companies and consultancies, in various roles, functions and therapeutic areas. He has been working in pharmacovigilance since 2004, spending more than 12 years as a QPPV. Among his achievements, he successfully set up the pharmacovigilance system of several small medium enterprises, and from the clinical development perspective, he received international awards for his research on an innovative treatment for ocular hypotony. Dr De Gregorio has a degree in Medicine from “La Sapienza” University of Rome, Italy, and specialised in ophthalmology, which practised for over 20 years. He has also a PhD in pathophysiology of ocular circulation.

Fabio De Gregorio


  • Thursday - November 2, 2023 - 12:20

    A new probabilistic algorithm for causality assessment and its use in signal detection


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now